Country: India
Sector: Healthcare
Website: https://www.lauruslabs.comLaurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
0.27% (5y avg: 0.36%)
1.60 INR
May 9, 2025
12.05%
Year | Total Dividends |
---|---|
2025 | 1.30 INR |
Nov. 23, 2025 (estimated) | 0.5000 |
May 20, 2025 | 0.8000 |
2024 | 0.80 INR |
Nov. 23, 2024 | 0.4000 |
May 25, 2024 | 0.4000 |
2023 | 1.60 INR |
Nov. 19, 2023 | 0.4000 |
May 27, 2023 | 1.2000 |
2022 | 2.40 INR |
Nov. 20, 2022 | 1.2000 |
May 28, 2022 | 1.2000 |
2021 | 2.00 INR |
Nov. 27, 2021 | 0.8000 |
May 29, 2021 | 0.8000 |
Feb. 27, 2021 | 0.4000 |
2020 | 2.10 INR |
Nov. 28, 2020 | 0.8000 |
Aug. 8, 2020 | 1.0000 |
March 27, 2020 | 0.3000 |
2019 | 1.50 INR |
Aug. 10, 2019 | 1.5000 |
2018 | 1.50 INR |
Aug. 4, 2018 | 1.5000 |
2017 | 1.50 INR |
Aug. 17, 2017 | 1.5000 |
Yearly aggregated dividends
Laurus Labs Limited
May 20, 2025 Paid
Dividend
0.8 INR |
Laurus Labs Limited
Nov 23, 2024 Paid
Dividend
0.4 INR |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion